Paper7694367
Inhibition by cAMP of Ras-dependent activation of Raf.
Cook SJ and 1 other. Science, 1993. Cited by 927 papers, by iCite.
Cite this record
ConductScience Library. Inhibition by cAMP of Ras-dependent activation of Raf. Papers, record 7694367. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7694367
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics23
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Calcium-Calmodulin-Dependent Protein Kinases | Major topic |
| Cyclic AMP | Major topic |
| Mitogen-Activated Protein Kinases | Major topic |
| Protein-Tyrosine Kinases | Major topic |
| Proto-Oncogene Proteins | Major topic |
| Proto-Oncogene Proteins p21(ras) | Major topic |
| Signal Transduction | Major topic |
| 1-Methyl-3-isobutylxanthine | |
| Animals | |
| Bucladesine | |
| Cell Line | |
| Cholera Toxin | |
| Cyclic AMP-Dependent Protein Kinases | |
| Enzyme Activation | |
| Epidermal Growth Factor | |
| ErbB Receptors | |
| Interphase | |
| Lysophospholipids | |
| Mitogen-Activated Protein Kinase 1 | |
| Mitogen-Activated Protein Kinase 3 | |
| Phosphorylation | |
| Proto-Oncogene Proteins c-raf | |
| Rats |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| UO1 CA51992-03 | NCI NIH HHS | United States | UO1CA519920 | PubMed | NIH RePORTER |
| U01CA051992 | NIH | NIH RePORTER |
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 8257559 | Two major signal pathways linked. | https://conductscience.org/library/papers/8257559 |
Source PubMed
Cited by225
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 927 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42816520 | Culture and gene expression profiling of Schwann cells from human sural nerve. | Commun Biol | 2026 | https://conductscience.org/library/papers/42816520 | PubMed |
| 40723563 | The Role of Gonadotropins and Growth Factor in Regulating Ras During Maturation in Cumulus-Oocyte Complexes of Pigs. | Animals (Basel) | 2025 | https://conductscience.org/library/papers/40723563 | PubMed |
| 39242543 | Light-gated integrator for highlighting kinase activity in living cells. | Nat Commun | 2024 | https://conductscience.org/library/papers/39242543 | PubMed |
| 38637546 | Disruption of the pro-oncogenic c-RAF-PDE8A complex represents a differentiated approach to treating KRAS-c-RAF dependent PDAC. | Sci Rep | 2024 | https://conductscience.org/library/papers/38637546 | PubMed |
| 38276879 | Calcium transients trigger switch-like discharge of prostaglandin E2 in an extracellular signal-regulated kinase-dependent manner. | Elife | 2024 | https://conductscience.org/library/papers/38276879 | PubMed |
| 38001841 | Multistep Approach Points to Compounds Responsible for the Biological Activity and Safety of Hydrolates from Nine Lamiaceae Medicinal Plants on Human Skin Fibroblasts. | Antioxidants (Basel) | 2023 | https://conductscience.org/library/papers/38001841 | PubMed |
| 37916285 | Vasopressin V2 receptor, tolvaptan, and ERK1/2 phosphorylation in the renal collecting duct. | Am J Physiol Renal Physiol | 2024 | https://conductscience.org/library/papers/37916285 | PubMed |
| 37644733 | The Adenylyl Cyclase Activator Forskolin Increases Influenza Virus Propagation in MDCK Cells by Regulating ERK1/2 Activity. | J Microbiol Biotechnol | 2023 | https://conductscience.org/library/papers/37644733 | PubMed |
| 36970578 | The ERK Signaling Cascade Inhibits Gonadotropin-Stimulated Steroidogenesis. | J Biotechnol Biomed | 2023 | https://conductscience.org/library/papers/36970578 | PubMed |
| 36313756 | The cAMP-signaling cancers: Clinically-divergent disorders with a common central pathway. | Front Endocrinol (Lausanne) | 2022 | https://conductscience.org/library/papers/36313756 | PubMed |
| 35805104 | cAMP Signaling in Cancer: A PKA-CREB and EPAC-Centric Approach. | Cells | 2022 | https://conductscience.org/library/papers/35805104 | PubMed |
| 35563547 | Discovery of Raf Family Is a Milestone in Deciphering the Ras-Mediated Intracellular Signaling Pathway. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35563547 | PubMed |
| 35253003 | c-JUN n-Terminal Kinase (JNK) Signaling in Autosomal Dominant Polycystic Kidney Disease. | J Cell Signal | 2022 | https://conductscience.org/library/papers/35253003 | PubMed |
| 34663687 | Gαs-Protein Kinase A (PKA) Pathway Signalopathies: The Emerging Genetic Landscape and Therapeutic Potential of Human Diseases Driven by Aberrant Gαs-PKA Signaling. | Pharmacol Rev | 2021 | https://conductscience.org/library/papers/34663687 | PubMed |
| 33869113 | The Controversy Persists: Is There a Qualification Criterion to Utilize Inhaled Nitric Oxide in Pre-term Newborns? | Front Pediatr | 2021 | https://conductscience.org/library/papers/33869113 | PubMed |
| 32777162 | Cyclic adenosine monophosphate (cAMP) signaling in melanocyte pigmentation and melanomagenesis. | Pigment Cell Melanoma Res | 2021 | https://conductscience.org/library/papers/32777162 | PubMed |
| 32694963 | Cryptochrome 1 Alleviates the Antiproliferative Effect of Isoproterenol on Human Gastric Cancer Cells. | Dose Response | 2020 | https://conductscience.org/library/papers/32694963 | PubMed |
| 32098410 | Kinome Profiling to Predict Sensitivity to MAPK Inhibition in Melanoma and to Provide New Insights into Intrinsic and Acquired Mechanism of Resistance. | Cancers (Basel) | 2020 | https://conductscience.org/library/papers/32098410 | PubMed |
| 31941155 | Targeting Aberrant RAS/RAF/MEK/ERK Signaling for Cancer Therapy. | Cells | 2020 | https://conductscience.org/library/papers/31941155 | PubMed |
| 31799192 | Does Ras Activate Raf and PI3K Allosterically? | Front Oncol | 2019 | https://conductscience.org/library/papers/31799192 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| MAPK1 | 5594 | PubTator's text mining | https://conductscience.org/library/genes/5594 | NCBI Gene |
| MAPK3 | 5595 | PubTator's text mining | https://conductscience.org/library/genes/5595 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/7694367
GET https://conductscience.org/api/papers/v1/7694367/cited_by?page=2